Company intelligence / Profile preview

HumanZyme

Chicago, Illinois, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

HumanZyme is not a therapeutic developer; it commercially supplies recombinant human proteins (cytokines, growth factors and related reagents) produced in human HEK293 cells for research, diagnostics, drug discovery, biopharmaceutical development and regenerative medicine manufacturing, including GMP-grade materials for clinical cell therapy applications.[1][3][4]

Modalities: Recombinant proteinProteinBiologic
Industry: Chemicals & Materials

Partnerships

PacificGMP (manufacture of GMP-certified recombinant growth factors and cytokines for human cell therapy applications)[4]

Beyond the preview

Go deeper on HumanZyme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HumanZyme.

Explore the full profile